fundament track posit
net dbt
rais estim momentum build top pick
report solid rais guidanc bullish tone growth
outlook next sever year notabl compani highlight current
consensu ep saw time lt target
high singl digit low doubl digit growth impli upsid estim especi
factor suspens health insur fee hif overal see lot get
excit compani grow doubl digit next sever year trade
ep rais estim unchang po base
ep vs previous reflect revis estim continu
strong trajectori reiter buy remain top pick
medicar advantag inflect point
assum see individu medicar advantag growth
line doubl digit organ growth commentari could impli
individu member meanwhil expect group membership
exceed impli compani doubl group
busi could see organ growth sinc group
busi would margin dilut year could creat anoth tailwind
margin ramp also sinc group busi grow nice four star
contract impact star rate declin like mute
fischbeck focu start multi-year growth
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter focu antm growth outlook manag
bullish commentari indic consensu see
low comparison indic
consensu reason rang antm commentari particularli
posit factor suspens hif high singl digit low doubl digit
growth impli potenti rang repres growth y/i
guidanc overal antm growth target impress
ep view stock attract risk/reward head acceler
growth profil new pharmaci contract kick
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
total benefit claim
total invest
oper return averag asset
long term debt cap ratio ex fa
amtz dac pre-tax profit bef amtz dac
one largest manag care
organ offer
commerci larg small employ medicar
medicaid individu market compani
oper cross shield plan
buy rate reflect view
valuat overli discount hc reform risk
undervalu compani growth profil
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter focu antm growth outlook manag
bullish commentari indic consensu see
low comparison indic consensu
reason rang antm commentari particularli posit factor
suspens health insur fee hif high singl digit low doubl digit
growth impli potenti rang repres growth y/i
guidanc overal antm growth target impress
ep view stock attract risk/reward head acceler
growth profil new pharmaci contract kick
discuss compani tick headwind appear
manag highlight regulatori uncertainti relat hif medicaid
group medicar advantag dilut new contract invest growth
headwind commentari around expect dilut new contract
medicaid group medicar advantag relat fact product
competit year econom usual drag compani time
implement medic manag case group get appropri
tailwind includ commerci fee base busi full year benefit
capit deploy time benefit hif
pois impress growth
industri number tailwind strong rate elimin hif
also benefit strong star score result expect grow
individu busi mid-teen believ ahead game
take advantag new rule allow cover non-tradit benefit
exampl partnership launch januari give medicar advantag
member allow purchas medic health relat item store
on-line meanwhil atnm continu focu caremor busi
improv health outcom compani improv sale platform broker
also support growth particularli given differenti ad benefit
time compani expect build recent win group
busi start becom focu recent year compani
expect group membership expect exceed compar
assum see individu growth line doubl digit
organ growth commentari could impli individu member
meanwhil compani expect group membership exceed
impli compani doubl group busi
could see organ growth sinc fact group
busi margin dilut year alreadi includ guidanc creat
anoth tailwind margin ramp also sinc group busi grow
nice four star contract impact star rate declin
mute previous expect
antm group growth trajectori key compani spread oper
cost across larger membership base achiev effici show
analysi antm scale drive lower sg spend per member per month
pmpm basi help bring compani target margin current
subscal group busi exampl would take two three year get
initi dilut popul get move target margin
upsid new pharmaci contract
make growth even impress us achiev
despit purchas drug market howev new pharmaci
contract antm cost structur result growth
sampl antm market cover enrol total estim cost
senior antm plan declin y/i averag market cost
declin y/i overal appear price conserv compani
seek integr recent deal improv margin busi
meanwhil ran similar analysi antm total estim drug cost ma-pd
plan market across sampl market total estim drug cost
senior antm plan declin y/i averag market cost
declin y/i impli price margin esrx contract roll
new pharmaci benefit manag pbm contract kick expect
price competit still maintain margin bode well
compani growth
tabl total cost drug cost vs market
conclus growth
overal impress growth outlook head
compani grow commerci risk non-risk medicar advantag meanwhil new
group medicaid busi come on-line expect margin
dilut turn tailwind given pharmaci agreement
alreadi slate start fulli phase end
appear teed strong growth next three year least
overview guidanc
histori conservat
note histor provid conserv guidanc beat
rais throughout year far guidanc impli beat vs initi
tabl initi guidanc compar actual result
adj ep guid rais color
increas adjust ep outlook compani
expect adjust ep least previou expect
new outlook impli year year growth least
guidanc rais driven lower expect year impli strong
lower guidanc basi point
previous sound like lower outlook due commerci
busi compani also lower cost trend outlook slightli versu
midpoint previous compani cite continu strength clinic
program continu declin inpati util
addit re-affirmed outlook revenu year-end enrol sg
ratio oper cash flow invest incom tax rate share count
earn call gave initi thought outlook overal
see lot momentum head see growth strengthen
manag note consensu slightli core growth expect
high singl digit/low doubl digit growth hif headwind
move base point
also mention expect tailwind headwind headwind
regulatori uncertainti hif medicaid group dilut new contract
invest drive futur revenu growth tailwind commerci fee
base busi growth full year benefit capit deploy time
benefit hif
relat busi expect mid-doubl digit individu medicar
advantag membership growth stabl margin manag note
acceler growth group expect group live
lower
slightli
amort
po base ep estim premium histor
averag justifi believ rel high potenti upsid
estim stand-alone risk upsid better-than-expect
enrol growth stronger growth medicar advantag time enhanc
buyback interest rate hike well lt benefit new pbm agreement
risk downsid worse-than-expect membership growth rise cost trend
greater-than expect hc reform disrupt
kevin fischbeck cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us facil hospit manag healthcar coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
